Andere Sprachen WuXi Biologics (Cayman) Inc.

Aktien

A2QJCN

KYG970081173

2269

Biotechnologie

Markt geschlossen - Hong Kong S.E. Andere Börsenplätze 09:08:04 09.12.2024			% 5 Tage	% 1. Jan.
19.00 ^HKD	+9.57%		+22.58%	-35.81%

09:48	Hongkong-Aktien beginnen die Woche im grünen Bereich; WuXi AppTec, WuXi Biologics springen um 9%	MT
05:04	Hochrangige Demokraten im US-Repräsentantenhaus lehnen den Ausschluss von mit China verbundenen Unternehmen aus der US-finanzierten Forschung ab	MT

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Hong Kong Stocks Begin Week in Green; WuXi AppTec, WuXi Biologics Jump 9%	09:48
Senior US House Democrats Oppose Blacklisting of China-Linked Firms from US-Funded Research	05:04
Crunch Time For BIOSECURE Act	04.12.
WuXi Biologics Inc. Announces Board and Committee Changes	20.11.
WuXi Biologics Cayman : Receives AAA MSCI ESG Rating for Second Consecutive Year	07.11.
WuXi Biologics Launches WuXia RidGS for Non-Antibiotic Cell Line Development	29.10.
WuXi Biologics Cayman : Launches WuXia™ RidGS for Non-Antibiotic Cell Line Development	28.10.
Medigene AG reports Financial Results and Business Update for Q3 2024	25.10.
WuXi Biologics Inc. completed the acquisition of remaining 30% stake in WuXi Vaccines Inc. from Shanghai Hile Bio-Technology Co., Ltd..	23.10.
WuXi Biologics Receives ESG Corporate Platinum Award from the Asset for Fourth Consecutive Year	17.10.
Hong Kong Stocks End Week Higher as Tech Counters Rally	04.10.
WuXi Companies' Shares Surge on Report of Potential Asset Sales	04.10.
WuXi AppTec, WuXi Biologics Seek Pharma Operations Sale Amid Pending US Restrictions	04.10.
WuXi Reportedly Explores Sale of Pharma Units as US Restrictions Loom	03.10.
Chinese Investors Buy More Hong Kong Stocks Ahead of National Day Break	02.10.
CANbridge Pharmaceuticals CAN103 for Gaucher Disease Granted Priority Review Status by CDE of the NMPA	01.10.
BIOSECURE Act: US To Target Chinese Biotechnology Companies	27.09.
WuXi Biologics Cayman : Included in Hang Seng ESG 50 Index	23.09.
Tranche Update on WuXi Biologics Inc.'s Equity Buyback Plan announced on December 7, 2023.	20.09.
BIOSECURE Act Passed In The House Of Representatives With A 306-81 Vote	20.09.
US Biosecure Act Could Boost South Korean Biotech Companies, Report Says	12.09.
China Condemns US House's Passing of Bill Targeting Biotech Companies	11.09.
European stocks mixed before eyes turn stateside	10.09.
WuXi Biologics (Cayman) Issues Response After US House OKs Biosecure Bill; Stocks Slide 4%	10.09.
WuXi Companies Say They're Not a Security Risk as U.S. Passes Draft of Biosecure Act -- Update	10.09.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen WuXi Biologics (Cayman) Inc.

Aktien

A2QJCN

KYG970081173

2269

Biotechnologie

Andere Sprachen

Filter